Research Goals
Research Protocol

Sexual Health & Libido

Research domain covering compounds that influence sexual arousal pathways, the hypothalamic-pituitary-gonadal axis, and reproductive endocrinology. Includes melanocortin receptor agonists, neuropeptides, and PDE5 inhibitors studied for their effects on sexual function and libido.

Research Use Only. The compounds listed below are documented for laboratory research and biochemical study only. Nothing here is medical advice, and no therapeutic or outcome claims are made. Not for human consumption.

12 Articles on This Research Goal

Clomiphene Citrate: Evidence-Based Research Review

6 min

Clomiphene citrate (CC) is a non-steroidal triphenylethylene derivative classified as a Selective Estrogen Receptor Modulator (SERM). Originally developed for the induction of ovulation in women with anovulatory infertility, it has become a cornerstone of reproductive medicine. CC operates as a race

Clinical Trial

Tamoxifen Citrate: Evidence-Based Research Review

6 min

Tamoxifen citrate is a non-steroidal triphenylethylene derivative and the prototypic Selective Estrogen Receptor Modulator (SERM). Originally developed as a contraceptive, it has become a cornerstone in the treatment and prophylaxis of estrogen receptor-positive (ER+) breast cancer. Tamoxifen exhibi

Clinical Trial

Testosterone Enanthate: Evidence-Based Research Review

6 min

Testosterone enanthate (TE) is a long-acting esterified formulation of the primary endogenous androgen, testosterone. Since its clinical introduction in the 1950s, it has served as a cornerstone for testosterone replacement therapy (TRT) in male hypogonadism and a reference compound in clinical rese

Clinical Trial

Toremifene Citrate: Evidence-Based Research Review

5 min

Toremifene citrate is a chlorinated triphenylethylene derivative and a second-generation selective estrogen receptor modulator (SERM). Structurally analogous to tamoxifen, toremifene was developed to maintain the therapeutic efficacy of ER-antagonism in breast tissue while potentially improving the

Clinical Trial

Raloxifene: Evidence-Based Research Review

6 min

Raloxifene is a second-generation selective estrogen receptor modulator (SERM) of the benzothiophene class. Developed to address the limitations of first-generation SERMs like tamoxifen, raloxifene exhibits distinct tissue-specific effects: it acts as an estrogen receptor (ER) agonist in bone and li

Clinical Trial

Melanotan II: Ξ±-MSH Analog Pharmacology, Clinical History, and Safety Profile

6 min

Melanotan II is a synthetic analog of Ξ±-melanocyte-stimulating hormone investigated in early-phase clinical trials for tanning and sexual dysfunction. This review summarizes its clinical evidence and notable safety concerns.

Clinical Trial

PT-141 / Bremelanotide: Melanocortin Agonist for Hypoactive Sexual Desire Disorder β€” Regulatory and Clinical Evidence

7 min

PT-141, developed as bremelanotide, is a melanocortin receptor agonist FDA-approved (Vyleesi) for premenopausal women with hypoactive sexual desire disorder. This review summarizes the registrational clinical evidence.

Clinical Trial

BPC-157 and Tissue Repair Signaling Pathways

9 min

Comprehensive review of BPC-157 mechanisms in tissue repair, angiogenesis, and mucosal healing.

Clinical Trial

Melanocortin Receptor Agonists and Neuroendocrine Signaling

8 min

Examination of melanocortin receptor signaling and synthetic agonist research applications.

Clinical Trial

Testosterone Enanthate vs Nandrolone: Evidence-Based Comparison

6 min

Testosterone Enanthate (TE) and Nandrolone Decanoate (ND) represent the two most common injectable anabolic-androgenic steroids (AAS) used in clinical and performance-enhancing contexts. Testosterone Enanthate serves as the gold standard for hormone replacement therapy (HRT) and as a physiological b

Peer-Reviewed

Raloxifene vs Tamoxifen: Evidence-Based Comparison

6 min

Selective Estrogen Receptor Modulators (SERMs) are a class of compounds characterized by their ability to act as estrogen receptor (ER) agonists or antagonists in a tissue-specific manner. Tamoxifen, a first-generation triphenylethylene SERM, and Raloxifene, a second-generation benzothiophene SERM,

Peer-Reviewed

Tamoxifen vs Clomiphene: Evidence-Based Comparison

6 min

Tamoxifen Citrate and Clomiphene Citrate are triphenylethylene-derivative Selective Estrogen Receptor Modulators (SERMs) that have been used extensively in clinical practice for over four decades. While both compounds share a similar chemical backbone, they exhibit distinct tissue-specific activitie

Peer-Reviewed

13 Compounds Studied Under This Goal

All compounds, protocols, and content are for research use only (RUO). This knowledge graph documents biochemical research pathways and is not a treatment guide. For laboratory and research purposes only.

ARIA Β· Sign in to chat